Company Facts & Figures

Our Mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients.

01

Enabling access to quality medicines and treatment options

1,800
medicines
40,000
employees
200,000,000
people served every day

Teva offers the world’s largest medicine cabinet - a full spectrum of products from generics, API and over-the-counter products to specialty and biologic treatments.

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 85 billion tablets and capsules a year 01. We have over 65 manufacturing facilities in more than 30 countries 01.

We rank among the leading pharmaceutical companies in the world and are active in 60 markets. Approximately 40,000 employees around the world are dedicated to our mission. Our innovative and high quality medicines serve about 200 million people every day 02.

Download PDF file
02

Focused specialty leadership centered on core therapeutic areas

Migraine

Movement disorders and neuro-degeneration

Respiratory

Pain

03

Global generic leadership

$
Billion
55
Annual savings to healthcare systems
in 18 of our markets in 2018

Top 3 leadership position in over 25 markets

1 in 10
prescriptions in the US
1 in 8
prescriptions in Germany
1 in 6
prescriptions in the UK
04

Strong operational base, global infrastructure and scale

65
production sites
85
billion tablets & capsules annually
05

A fully integrated R&D function

25 R&D and clinical development sites.

1000 generic approvals globally in 2019.

100
pending first-to-file ANDAs in the U.S.
200
product registrations pending FDA approval
500+
pending product approvals in International Markets
06

Global reach

60
commercial markets
3,500
different products in our global portfolio

Notes and References

  1. Back to contents.

    Data source for number of products & facilities: Teva Global Operations

  2. Back to contents.

    Internal analyses conducted by Global Insights, Access & Technologies estimating number of Teva consumers. Ref 2.1 dated August 2016; Ref 2.2 dated April 2019

Data confirmed as of May 2020